Venture Leaders Medtech 2021
We are excited to be among the 10 new members of the Swiss National Startup team! A jury of professional investors and medtech experts reviewed almost 70 applications to choose the Venture Leaders Medtech 2021. Previously, medtech startups participated in the Venture Leaders Life Sciences program and were now dedicated their own Venture Leaders program, as it has become such an important field in Switzerland.
On behalf of hemotune, our CEO Lukas Langenegger will travel to Boston next fall. There, he will dive into the US medtech startup ecosystem, meet international investors, as well as industry leaders, and access industry specific expertise and networks. This is a great opportunity to accelerate hemotune's expansion and build global business networks.
Click here to learn more about this particular event.